male sexual dysfunction
Conditions
Interventions
group 1 will receive 12.5 mg paroxetine daily for 2 months then gradual tapering for 2 weeks then a 2 week washout period
group 2 will receive 20 mg paroxetine daily for 2 months then gradual tapering
Sponsors
Kasr alainy cairo university
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: The patients married for at least 1 year with stable and continuous marital relationship. They will be asked not to use condoms, topical anaesthetic cream or spray before sexual intercourse. They will be presented with lifelong PE (intravaginal latency time <2??in) and inability to satisfy their partners. None of them had any formal psychosexual counselling.
Exclusion criteria
Exclusion criteria: Patients with erectile dysfunction (men having International Index of Erectile Function (IIEF) score (validated Arabic version) <21), reduced sexual desire or inhibited male orgasm were excluded from the study. In addition, patients with presence of mental disorders, physical illnesses affecting ejaculatory function, abuse of alcohol or recreational drugs and any psychotropic medications that may affect response to SSRIs or any medical treatment for premature ejaculation in the past 6 months were also excluded. Also, patients with urinary tract infection will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| evaluating the effect of different doses of Paroxetine in premature ejaculation | — |
Secondary
| Measure | Time frame |
|---|---|
| safety profile and complications of different doses of Paroxetine in premature ejaculation | — |
Countries
Africa
Contacts
Public ContactSameh GamalEl Din
Cairo University Andrology & STDs
Outcome results
None listed